A Study to Investigate Safety, Tolerability and Pharmacokinetics of REM0045392 Compared With Placebo in Healthy Participants.

NCT07016464 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

19

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Healthy

Interventions

DRUG: REM0045392
DRUG: Placebo

Sponsor

reMYND